Top Markets
Coin of the day
20/20 Biolabs Inc. 20/20 Biolabs Inc.

20/20 Biolabs Inc.

AIDX
Classificação em ações #33864
20/20 GeneSystems, Inc. operates as a clinical laboratory testing company... 20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.
Preço da ação
$0.5475
Última sincronização: 2026-08-14
Valor de mercado
$6.71M
Variação (1 dia)
5.57%
Variação (1 ano)
-
País
US
Negociar 20/20 Biolabs Inc. (AIDX)

Categoria

Histórico de preços das ações de 20/20 Biolabs Inc. (AIDX)
Preço de fecho mais alto: $0.48 em 2026-08-01

Preço de fecho mais baixo: $10.07 em 2026-02-01
Histórico de preços das ações da 20/20 Biolabs Inc. de 2026 a 2026
Desempenho anual do preço das ações
Ano Desempenho
Não há dados suficientes para as datas fornecidas.
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$404.45 2.19%
US
$55.84 3.68%
DE
$61.49 -9.30%
SA
$266.94 55.18%
US
$2.09 29.32%
MY